Boutique Consultancy in CNS Clinical Development
Dr Evan Papanastasiou | MD MSc PhD MBA
Pharmaceutical Physician, Clinical Neuroscientist & Psychiatrist.
“Quality means doing it right, when no one is looking.”
Henry Ford, American Industrialist
Overview of Consultancy
We offer three major consultancy roles in clinical development, namely lead physician, medical monitor and clinical scientist. These can be contracted by a pharmaceutical sponsor or a CRO company who wish to outsource selected clinical development activities. However, most companies might need bespoke hybrid roles, which we can equally accommodate.
Lead Physician
Leadership and medical expertise for CNS trials; ensure study compliance; overview of clinical documentation; interpret & document data; collaborate with leading academic centres & other stakeholders; represent clinical teams in internal and external meetings.
Medical Monitor
Monitor the quality and consistency of clinical data; review adverse events, laboratory and clinical data; handle protocol deviations; prepare for safety monitoring meetings; effectively communicate with sponsor and investigators.
Clinical Scientist
Review medical literature; author publications & presentations; evaluate clinical applications of novel compounds; participate in life-cycle management discussions; organise advisory boards & scientific communication activities.
“Quality is not an act; it is a habit.”
Aristotle, Greek Philosopher
About EvanMed
We are committed to promote CNS drug development; we benefit from a wide range of clinical and scientific experience; we generate high-quality scientific output in a timely, efficient manner.
Experience
We have gained substantial and varying professional experience in the pharmaceutical sector, the academia and the health sector, having focused primarily in the CNS.
Publications
We have produced a variety of publications including scientific articles in high-impact factor journals and corporate presentations, in CNS-related topics.
Mission
We aim to promote the development of new effective drugs in CNS indications, placing the safety and well-being of patients at our highest priority.
We are equipped with good science, evidence-based practice and diverse clinical experience to deliver our goals.
We are focused on high-quality outcomes, pay attention to details but also afford adequate flexibility to accommodate our clients’ needs.